Pharmacologic treatments for covid-19 patients

CIGB-325 vs Standard care


Hospitalized patients

Forest plots
(last update: 2021-06-10)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=94

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
RPCEC00000317
ATENEA-Co-300
Cruz LR, ACS Pharmacol. Trans, 2020
Full text
Commentary
Commentary
Mixed

CIGB-325

Standard care

RCT Patients with confirmed COVID-19 (asymptomatic-severe) admitted to a single center in Cuba N=20
Some concerns
Details

Full description